4//SEC Filing
Chrousos Phaedra 4
Accession 0001209191-19-037409
CIK 0001347178other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:01 PM ET
Size
7.3 KB
Accession
0001209191-19-037409
Insider Transaction Report
Form 4
Chrousos Phaedra
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-13+10,000→ 10,000 totalExercise: $15.04Exp: 2029-06-12→ Common Stock (10,000 underlying) - Award
Common Stock
2019-06-13+5,000→ 5,000 total
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 13, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on June 13, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001774518
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:01 PM ET
- Size
- 7.3 KB